Cardiology Flashcards
Unstable ACS - pathophysiology
Lipid rich plaques that erode, rupture and thrombose with associated inflammation
Stable angina - pathophysiology
Plaques cap over and inflammation settles, leading to demand ischaemia.
How do you estimate the probability of significant CAD?
CVD risk calculator - age, gender, smoking status, diabetes, HTN, cholesterol, Māori/Indigenous
Define typical angina
- Constricting discomfort in front of chest, or neck, jaw, shoulder, arm.
- Precipitated by physical exertion
- Relieved by rest or nitrates within 5mins.
Define atypical angina
Meets 2 of the typical angina characteristics
Define non-angina chest pain
Meets 1 or none of typical angina characteristics
Describe grading for angina
I. Angina only with strenuous, rapid or prolonged exercise e.g. walking, climbing stairs
II. Angina with moderate exertion - slight limitation of ordinary activities if performed rapidly, after meals, in cold, under stress, walking uphill or >1 flight of stairs at normal pace.
III. Angina with mild exertion - having difficulties walking 1-2 blocks or climbing 1 flight of stairs.
IV. Angina at rest
What percentage of ischaemic presentats with pleuritic chest pain?
5-19% of ACS
What percentage of patients have tenderness on chest wall palpation with AMI?
~15%
Who are more likely to present with atypical angina presentations?
Elderly, females, or people with diabetes
What are modifiable risk factors in terms of CAD?
Diet, obesity, alcohol (<15g/day), smoking, hypertension (lifestyle modification first, then meds), dyslipidaemia (LDL <1.4mmol/L), diabetes (aim near normal HbA1c), physical activity, cardiac rehabiliation.
Describe pharmacotherapy of chronic angina
Aspirin (indefinitely; can use ticagrelor/clopidogrel if aspirin intolerance, add if high risk features), B-blocker, ACE/ARB, statin. GTN spray for immediate symptoms, long acting nitrates for symptoms.
Describe role of revascularisation in chronic CAD
- Clinical context is most important.
- Stents/PCI target culprit lesions
- CABG targets culprit + some non-culprit lesions proximal to the bypass
- Sicker patients have the most to gain from revascularisation.
Describe key points of COURAGE study
- In patients who don’t have significant angina or impaired LV function, optimal medical therapy has equivalent survival.
Describe key points of ISCHAEMIA trial
Only applicable to people with stable CAD not ACS or high risk subsets.
1. No benefit of conservative vs invasive approach in people with stable CAD up to 5yrs.
2. Angina relieved early on with invasive approach
Prognostic improvement with revascularisation in chronic angina is associated with:
- Evidence/extent of ischaemia - refractory angina or life limiting symptoms
- Evidence of large area of ischaemia - Evidence of impaired cardiac function
Definition of acute myocardial infarction:
Elevated troponin + ONE of: symptoms, ECG changes, imaging evidence, angiography or autopsy.
Define type 1 MI:
atherosclerotic plaque rupture, ulceration, fissure or erosion with resulting intraluminal thrombus in one or more coronary arteries leading to decreased myocardial blood flow and/or distal embolisation and subsequent myocardial necrosis
Define T2MI:
Myocardial necrosis in which a condition other than coronary plaque instability causes an imbalance between myocardial oxygen supply and demand.
Causes of T2MI:
Extremes of BP (hypotension/hypertension), tachyarrhythmias, bradycarrhythmias, anaemia, hypoxaemia, coronary artery spasm, spontaenous coronary artery dissection (SCAD), coronary embolism
Define Type 3-5 MI
Type 3: MI resulting in death when biomarkers are not available.
Type 4+5: related to PCI and CABG
List differentials for chest pain
- Ischaemic cardiovascular causes: ACS, stable angina, severe aortic stenosis, tachyarrhythmia (atrial or ventricular).
- Non-ischaemic cardiovascular causes: aortic dissection, PE, pericarditis, myocarditis.
- Non-cardiovascular causes: GI, MSK (costochronditis, cervical radiculopathy); pulmonary (pneumonia, pleuritis, pneumothorax); other